Induced Pluripotent Stem Cells Market Soars at 12.23% CAGR Between 2019 and 2025

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Los Angeles, United States - September 12, 2019 /MarketersMedia/ —

In a recent research report published by QY Research, titled, “Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025” has analyzed the global induced pluripotent stem cells market. The report is a depth research paper about the various areas of the market, namely, market size, drivers and restrains, segment analysis, regional analysis, key players, and competitive landscape.

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1243625/global-induced-pluripotent-stem-cells-market

Global Induced Pluripotent Stem Cells Market: Drivers and Restraints

The global induced pluripotent stem cells market is expected to grow with its increasing usage as a regenerative medicine for damaged tissues and diseased organs. This is attributed towards an interesting property of pluripotent stem cells to form various types of adult cells such as neurons, liver, heart, and pancreatic cells. They also can make any cell or tissue combat diseases such as spinal cord injury, diabetes, heart disease, and leukaemia. These cells can be modified to match patient’s genetic makeup. Governments and private sectors are investing heavily in the development of pluripotent stem cells as they enable initial human growth. Its ability to produce customized cells, rejection-proof cells, and tissues for efficacious transplantation is expected to offer lucrative opportunities to the global market for induced pluripotent stem cells.

Increasing interest among scientists to understand and develop stem cells for various ailments is expected to contribute towards the growth of stem cells. Its various roles in clinical applications, research and awareness among people about the benefits of stem cells will boost the market growth during the forecast period.

However, the treatment and reprogramming of cells is a lengthy and costly process. Also the market has certain ethical risks associated with it. Other factors like low efficiency, proliferation rates, potential tumour risk, and incomplete programming can hamper the growth of the global induced pluripotent stem cells market.

Global Induced Pluripotent Stem Cells Market: Segment Analysis

The global induced pluripotent stem cells market is segmented on the basis of type and application. The type segment includes human iPSCs and mouse iPSCs. The application segment includes academic research, drug development and discovery, toxicity screening, regenerative medicine, and others.

Global Induced Pluripotent Stem Cells Market: Regional Analysis

The report analysis various region of the global induced pluripotent stem cells market such as United States, Europe, Asia Pacific (China, India, and Japan), Southeast Asia, Central & South America, and other regions. The market is expected to grow in regions like Asia due to increasing number of research projects. Currently, North America dominates the global market, followed by Europe.

Global Induced Pluripotent Stem Cells Market: Key Players

The key players covered in the report are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc., Fate Therapeutics, Inc., Pluricell Biotech, Cell Inspire Biotechnology, and ReproCELL.

Global Induced Pluripotent Stem Cells Market: Competitive Landscape

Fujifilm Holding Corporation (CDI) is a leading company. They recently announced a collaboration with Axcelead Drug Discovery Partners, Inc. to provide integrated platform for drug discovery solutions. Both the companies will together work towards developing new drug efficacy evaluation methods. They will also develop toxicity testing to meet specific client needs. They will also work towards R&D of iPSC to study ability to differentiate into diverse cells and its infinite reproduction capabilities. As the demand for iPSC is expected to grow further they are planning a standardizing safety tests using differentiated cells.

The increasing competition amongst manufactures is fuelling the need for developmental strategies such as product development, innovative technologies, and joint ventures to boost share in the market. This strategy of Fujifilm Holding Corporation (CDI) is expected to push the company towards significant development in the medical field and set high benchmark for other manufacturers.

Get Complete Report in your Inbox within 24 hours at 3,900 USD https://www.qyresearch.com/settlement/pre/eb11190375650824d3d7695db8b374ce,0,1,Global-Induced-Pluripotent-Stem-Cells-Market-Size-Status-and-Forecast

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.

Contact Info:
Name: Rahul Singh
Email: Send Email
Organization: QY Research, Inc
Address: QY Research, INC. 17890 Castleton, Suite 218, Los Angeles, CA - 91748
Phone: 6264288800
Website: https://www.qyresearch.com/index/detail/1243625/global-induced-pluripotent-stem-cells-market

Source URL: https://marketersmedia.com/induced-pluripotent-stem-cells-market-soars-at-1223-cagr-between-2019-and-2025/88918267

Source: MarketersMedia

Release ID: 88918267

Latest News

China lets currency sink to 11-year low after Trump threats

Sep 20, 2019

BEIJING — China allowed its yuan to sink to an 11-year low Monday after President Donald Trump sent jittery financial markets tumbling by announcing new tariff hikes and threatening to block American companies from doing business with this country. The escalation in the fight over trade and technology prompted warnings that chances for a settlement were disappearing. The yuan declined to 7.1468 to the dollar, a relatively modest change from Friday's low point of 7.0927 but its weakest rate since January 2008. The yuan has lost 6.5% from this year's high on Feb. 28. Chinese leaders have promised to avoid...

China threatens retaliation if US tariff hikes go ahead

Sep 20, 2019

BEIJING — China on Thursday threatened retaliation if Washington steps up their war over trade and technology by going ahead with planned Sept. 1 tariff hikes on additional Chinese imports. Beijing will take unspecified "necessary countermeasures," the Cabinet said in a one-sentence statement. It gave no details or any indication plans for trade talks in Washington in September might be affected. The mounting tension has unnerved financial markets that worry the global economy will tip into recession. President Donald Trump says he plans to impose 10% duties on an additional $300 billion of Chinese imports, extending penalties to almost everything...

China's Xi gets tougher on Trump after new tariff threat

Sep 20, 2019

BEIJING — Facing another U.S. tariff hike, Chinese President Xi Jinping is getting tougher with Washington instead of backing down. Beijing fired what economists called a "warning shot" at Washington by letting its yuan currency weaken in response to President Donald Trump's latest threat of more punitive import duties on Sept. 1. Chinese buyers canceled multibillion-dollar purchases of U.S. soybeans. Regulators are threatening to place American companies on an "unreliable entities" list that might face curbs on their operations. Both sides have incentives to settle a trade war that is battering exporters on either side of the Pacific and threatening...

US says new round of talks with China were 'constructive'

Sep 20, 2019

SHANGHAI — U.S. and Chinese envoys held "constructive" trade talks on Wednesday, the White House said, after President Donald Trump rattled financial markets by accusing Beijing of trying to stall in hopes he will fail to win reelection in 2020. The meeting, aimed at ending a tariff war over trade and technology, ended about 40 minutes ahead of schedule. Neither delegation spoke to reporters before U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin left for the airport. But White House spokeswoman Stephanie Grisham said in a statement hours later that "the meetings were constructive," and that talks are...

China imports from US plunge 31% in June amid tariff war

Sep 20, 2019

BEIJING — China's imports from the United States plunged in June amid a tariff war with Washington while exports to the U.S. market weakened. Imports of U.S. goods fell 31.4% from a year earlier to $9.4 billion, while exports to the American market declined 7.8% to $39.3 billion, customs data showed Friday. China's trade surplus with the United States widened by 3% to $29.9 billion. U.S.-Chinese trade has weakened since President Donald Trump started hiked tariffs last year on goods from China in a fight over Beijing's technology ambitions. China retaliated with penalty duties and ordered importers to find non-U.S....

Scienfinite is created to inspire our readers with the aim to understand the world and appreciate its everyday awe. Keep up with the technology and latest innovations here, only in Scienfinite.